Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$243,484
+$25,324 QoQ
Shares Held
203
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#4,305
of 4,605 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ranch Capital Advisors Inc. holds $19,506,059 across 8 Drug Manufacturers - General names. LLY ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,434 | $4,427,712 | |
| 2 | AMGN |
Amgen Inc
|
12,108 | $4,384,548 | |
| 3 | ABBV |
AbbVie Inc.
|
16,101 | $4,051,655 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
29,324 | $3,704,794 | |
| 5 | PFE |
Pfizer Inc
|
85,339 | $2,054,963 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,727 | $329,989 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,404 | $308,914 | |
| 8 | LLY |
ELI LILLY & Co
This page
|
203 | $243,484 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $243,484 | 203 | Shares | Sole | 2026-08-03 | |
| 2025-12-31 | $218,160 | 203 | Shares | Sole | 2026-02-05 | |
| 2021-09-30 | $33,502 | 145 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $33,050 | 144 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $26,902 | 144 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $24,312 | 144 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $21,166 | 143 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $23,477 | 143 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $19,836 | 143 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||